levo, Author at Baysient

Baysient’s Commitment to COVID-19 Safety

March 25, 2020
levo
News
0 Comments

Coronavirus (COVID-19) is officially a worldwide pandemic as it continues to spread globally. The doctors and researchers on the Baysient team are actively developing treatments for COVID-19 to help end the death toll it has caused around the world. For…

Digital Health Company Baysient Announces CDS/HCEI Software to Reduce Healthcare Cost in the Biosimilar Market

February 28, 2020
levo
Press Releases
0 Comments

Ft. Myers FL, February 28, 2020 - Baysient® LLC’s founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics and Precision Medicine in IBD at Canadian Digestive…

Canadian Digestive Diseases Week

February 21, 2020
levo
Blog Posts

Canadian Digestive Diseases Week (CDDW) is Canada’s premier educational conference, showcasing the newest research in gastroenterology and hepatology.

Baysient at CDDW

February 7, 2020
levo
Blog Posts

Baysient will be attending the Canadian Digestive Diseases Week conference from Friday, February 28, 2020 - Sunday, March 1, 2020 in Montreal, Quebec, Canada!

Welcome to Baysient

January 31, 2020
levo
Blog Posts

Hello, and welcome to Baysient, a revolutionary compuceutical company changing the way physicians dose patients. Think computer meets pharmaceutical; that’s how our compuceutical software...